Tin tức & Cập nhật

Dupilumab eases itch, disease activity in chronic spontaneous urticaria
Dupilumab eases itch, disease activity in chronic spontaneous urticaria
16 Mar 2025 bởiStephen Padilla

Patients with chronic spontaneous urticaria (CSA) who has uncontrolled disease despite treatment with H1-antihistamines may benefit from using dupilumab, which has been shown to reduce itch and urticaria activity in two phase III trials.

Dupilumab eases itch, disease activity in chronic spontaneous urticaria
16 Mar 2025